Company: RPTX
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030405
Chunk: 78

Company: Repare Therapeutics Inc.
Filing Date: 2025-03-03
Form: 10-K
Item: Item 1B
Chunk 78
---
We have served as the Company’s auditor since 2017.

Montréal, Canada

March 3, 2025

101

Repare Therapeutics Inc. 

Consolidated Balance Sheets 

(In thousands of U.S. dollars, except share data) 

    As of December 31,

    2024

    2023

    ASSETS

    Current assets:

    Cash and cash equivalents
     
    $
    84,717

    $
    111,268

    Marketable securities

    68,074

    112,359

    Income tax receivable

    10,600

    10,813

    Other current receivables

    1,746

    4,499

    Prepaid expenses

    6,012

    4,749

    Total current assets

    171,149

    243,688

    Property and equipment, net

    2,294

    4,215

    Operating lease right-of-use assets

    1,924

    3,326

    Income tax receivable

    960

    2,276

    Other assets

    179

    396

    TOTAL ASSETS
     
    $
    176,506

    $
    253,901

    LIABILITIES AND SHAREHOLDERS’ EQUITY

    Current liabilities:

    Accounts payable
     
    $
    3,623

    $
    2,400

    Accrued expenses and other current liabilities

    19,819

    24,057

    Operating lease liabilities, current portion

    1,845

    2,400

    Deferred revenue, current portion

    —

    10,222

    Total current liabilities

    25,287

    39,079

    Operating lease liabilities, net of current portion

    88

    1,010

    Deferred revenue, net of current portion

    —

    1,730

    TOTAL LIABILITIES

    25,375

    41,819

    Commitments and Contingencies

    SHAREHOLDERS’ EQUITY:

    Preferred shares, no par value per share; unlimited shares authorized as of  December 31, 2024 and December 31, 2023; 0 shares issued and outstanding  as